2016-11-03 |
1 |
|
United States Patent Nos. 8,246,979 (“the ’979 Patent”); 8,246,980
(“the ’980 Patent”); 8,617,591 (“…infringement of the ’979 Patent; the ’980 Patent;
the ’591 Patent; and the ’434 Patent. This Court has jurisdiction… 1. This action for patent infringement, brought pursuant to the patent laws of the
United States…(“the ’591 Patent”); and 6,884,434 (“the ’434 Patent”). Plaintiffs
Case 1:16-cv-01023-LPS Document 1…. This civil action for patent infringement arises under the patent laws of the United
States, including |
External link to document |
2018-05-25 |
133 |
Notice of Service |
Initial Infringement Contentions for U.S. Patent No. 9,925,150 B2 filed by LTS Lohmann Therapie-Systeme…2016
7 October 2020
1:16-cv-01023
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-06-01 |
137 |
Opinion - Memorandum Opinion |
Zydus"), alleging infringement of U.S. Patent Nos. 6,884,434,
8,617,591, and 8,246,979.
Presently…one
term appearing in the '434 patent. The '434 patent describes and claims transdermal therapeutic…; It is a bedrock principle of patent law that the
claims of a patent define the invention to which the…reading the entire patent." Id. at 1321
(internal quotation marks omitted). The patent specification …13 of the ' 979 patent and claims 1, 2, 3, 10, and 11 of the
'59 1 patent, as "particulate |
External link to document |
2018-06-27 |
145 |
Patent/Trademark Report to Commissioner of Patents |
,246,980 ;8,617,591 ;6,699,498 ;7,413,747 . (Phillips, John) (Entered: 06/27/2018)
27 June 2018
… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,246,979 ;8,246,980…2016
7 October 2020
1:16-cv-01023
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-06-27 |
147 |
Notice of Service |
Initial Invalidity Contentions for U.S. Patent No. 9,925,150 filed by Zydus Pharmaceuticals USA, Inc.…2016
7 October 2020
1:16-cv-01023
830 Patent
None
District Court, D. Delaware
|
External link to document |